XETRA - Delayed Quote • EUR
Bayer Aktiengesellschaft (BAYN.DE)
At close: 5:39 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
47,637,000.00
47,637,000.00
50,739,000.00
44,081,000.00
41,400,000.00
Cost of Revenue
19,749,000.00
19,749,000.00
19,871,000.00
16,816,000.00
19,138,000.00
Gross Profit
27,888,000.00
27,888,000.00
30,868,000.00
27,265,000.00
22,262,000.00
Operating Expense
19,852,000.00
19,852,000.00
23,535,000.00
20,356,000.00
22,976,000.00
Operating Income
8,036,000.00
8,036,000.00
7,333,000.00
6,909,000.00
-714,000.00
Net Non Operating Interest Income Expense
-1,611,000.00
-1,611,000.00
-1,823,000.00
-945,000.00
-1,271,000.00
Pretax Income
-1,621,000.00
-1,621,000.00
4,670,000.00
2,046,000.00
-17,250,000.00
Tax Provision
1,321,000.00
1,321,000.00
504,000.00
1,024,000.00
-1,689,000.00
Net Income Common Stockholders
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-10,495,000.00
Diluted NI Available to Com Stockholders
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-10,495,000.00
Basic EPS
-2.99
-2.99
4.22
1.02
-10.68
Diluted EPS
-2.99
-2.99
4.22
1.02
-10.68
Basic Average Shares
982,420.00
982,420.00
982,420.00
982,420.00
982,420.00
Diluted Average Shares
982,420.00
982,420.00
982,420.00
982,420.00
982,420.00
Total Expenses
39,601,000.00
39,601,000.00
43,406,000.00
37,172,000.00
42,114,000.00
Net Income from Continuing & Discontinued Operation
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-10,495,000.00
Normalized Income
10,068,750.00
10,068,750.00
5,304,132.00
3,507,400.00
156,606.00
Interest Income
484,000.00
484,000.00
379,000.00
346,000.00
202,000.00
Interest Expense
2,047,000.00
2,047,000.00
1,857,000.00
1,347,000.00
1,596,000.00
Net Interest Income
-1,611,000.00
-1,611,000.00
-1,823,000.00
-945,000.00
-1,271,000.00
EBIT
426,000.00
426,000.00
6,527,000.00
3,393,000.00
-15,654,000.00
EBITDA
10,446,000.00
10,446,000.00
13,030,000.00
6,449,000.00
-2,395,000.00
Reconciled Cost of Revenue
19,749,000.00
19,749,000.00
19,871,000.00
16,816,000.00
19,138,000.00
Reconciled Depreciation
10,020,000.00
10,020,000.00
6,503,000.00
3,056,000.00
13,259,000.00
Net Income from Continuing Operation Net Minority Interest
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-15,569,000.00
Total Unusual Items Excluding Goodwill
-7,435,000.00
-7,435,000.00
-471,000.00
-3,582,000.00
-14,953,000.00
Total Unusual Items
-745,000.00
-745,000.00
263,000.00
-3,582,000.00
-12,715,000.00
Normalized EBITDA
11,191,000.00
11,191,000.00
12,767,000.00
10,031,000.00
10,320,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,115,250.00
-1,115,250.00
-50,868.00
-1,074,600.00
-1,465,394.00
12/31/2020 - 12/16/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ROG.SW Roche Holding AG
221.00
+1.01%
NOVN.SW Novartis AG
89.50
-0.56%
SAN.PA Sanofi
91.23
-0.43%
GRF.MC Grifols, S.A.
8.39
+3.71%
NVS Novartis AG
97.44
-1.64%
PFE Pfizer Inc.
25.40
+0.55%
SNY Sanofi
49.13
-0.47%
BMY Bristol-Myers Squibb Company
44.85
+0.34%
GSK GSK plc
41.11
+0.49%
JNJ Johnson & Johnson
146.14
-0.46%